Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Total 13F shares
-
66,279,662
-
Share change
-
+1,869,480
-
Total reported value
-
$934,552,606
-
Put/Call ratio
-
93%
-
Price per share
-
$14.10
-
Number of holders
-
157
-
Value change
-
+$30,528,224
-
Number of buys
-
65
-
Number of sells
-
85
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2021
As of 31 Dec 2021,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,279,662 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., FIRST TRUST ADVISORS LP, STATE STREET CORP, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, Soleus Capital Management, L.P., JACOBS LEVY EQUITY MANAGEMENT, INC, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
157
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.